4//SEC Filing
Kharabi Darius 4
Accession 0001415889-23-010287
CIK 0001479419other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 8:00 PM ET
Size
7.7 KB
Accession
0001415889-23-010287
Insider Transaction Report
Form 4
Kharabi Darius
CHIEF BUSINESS OFFICER
Transactions
- Award
Common Stock
2023-06-22+36,847→ 61,902 total - Award
Stock Option (right to buy)
2023-06-22+49,129→ 49,129 totalExercise: $14.56Exp: 2033-06-21→ Common Stock (49,129 underlying)
Footnotes (3)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued employment with Issuer, the RSUs will vest as to 1/3 of the shares underlying the RSUs on June 22, 2024, as to 1/3 of the shares underlying the RSUs on June 22, 2025 and as to the final 1/3 of shares underlying the RSUs on June 22, 2026.
- [F2]Includes 49,020 unvested RSUs.
- [F3]This option was granted on June 22, 2023 and vests over four years beginning on the vesting commencement date of June 22, 2023, with 25% of the shares underlying the option vesting on June 22, 2024, and an additional 1/48th the shares underlying the option vesting at the end of each successive one-month period thereafter.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001893729
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 8:00 PM ET
- Size
- 7.7 KB